Trial intelligence / Profile preview

Phase III randomized trial of intramuscular peramivir for uncomplicated acute influenza

2007-002527-32Phase 3Completed

Sponsor
BioCryst Pharmaceuticals, Inc.
Start
Jun 2007
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in influenza comparing Peramivir intramuscular with Placebo intramuscular (2 arms). Primary endpoint: Time to alleviation of clinical symptoms of influenza. Started Jun 2007; status: completed.

02

Drugs

peramivir
03

Conditions

influenza

Beyond the preview

Go deeper on 2007-002527-32.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-002527-32.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call